Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors

Autor: Daniël H. van Raalte, Melanie van Nieuwenhuijzen, Nel Willekes, Erik J.M. van Bommel, Isabel T.N. Nguyen, Jaap A. Joles, Rosalie A. Scholtes

Publikováno v: Kidney International Reports, 5(11), 2052-2054. Elsevier Inc.
Kidney International Reports
Scholtes, R A, Nguyen, I T N, van Bommel, E J M, Willekes, N, van Nieuwenhuijzen, M, van Raalte, D H & Joles, J A 2020, ' Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors ', Kidney International Reports, vol. 5, no. 11, pp. 2052-2054 . https://doi.org/10.1016/j.ekir.2020.09.002

Para-aminohippuric acid (PAH)-derived effective renal plasma flow (ERPF) is increasingly being used in parallel with the revived interest in kidney hemodynamic function due to the development of sodium glucose co-transporter 2 (SGLT2) inhibitors. In

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2217aa8cef4825af92e02b3b415018b
https://research.vumc.nl/en/publications/50112c20-3e8d-4517-b5d5-e1751032f0e3